Clinical trial · Interventional
Surgical Management of Multiple Mucoepidermoid Carcinoma and Adenocarcinoma
NCT03988959CI-TRIAL-00039121completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
A case series of patient having mucoepidermoid carcinoma, had standard treatment protocol and surgeries and followup was performed and the patient postoperative quality of life and recurrent rate was recorded
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Adenocarcinoma; Mucoepidermoid Carcinoma | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| resection of mucoeidermoid carcinoma | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- OTHER
- label
- Control
- description
- Standard resection
- interventionNames
- Procedure: resection of mucoeidermoid carcinoma
Primary outcomes (1)
- measure
- Quality of life
- timeFrame
- 6 months
- description
- in grades the quality of life of patients is assessed by visual analogue scale in a scale from 1-10. higher values indicates better quality of life
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 20 Years
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: * patients suffering from salivary gland tumor Exclusion Criteria: * healthy patients with no tumors
References
Publications (0)
Data not yet available
No reference posted for this study.